Hypertension treatment is on the right pathway

I reported previously (Mar 2012) about the invasively implantable MobiusHD device from Israel’s Vascular Dynamics which reduces high blood pressure. MobiusHD is undergoing trials, has CE approval and is on the FDA’s Expedited Access Pathway program. It has also just received $10.4 million of funds.




This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *